Study looks at effects of low-, high-dose statins on diabetes

04/24/2012 | Medscape (free registration)

Patients who were on high-dose statin treatment did not appear to have a higher risk of developing new-onset diabetes compared with their counterparts who were on low-/moderate-dose statin therapy, an analysis found. Larger prospective studies are needed to examine the risks and benefits of long-term statin use in people at high risk of diabetes, the study's lead author said. The results were presented at the World Congress of Cardiology 2012.

View Full Article in:

Medscape (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY